Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2014

01-12-2014 | Original Article

Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases

Authors: Jun Wu, Shengqiang Yu, Vickram Tejwani, Michael Mao, Angela K. Muriithi, Chaoyang Ye, Xuezhi Zhao, Hongchen Gu, Changlin Mei, Qi Qian

Published in: Clinical and Experimental Nephrology | Issue 6/2014

Login to get access

Abstract

Background

The objective of this study is to investigate the frequency and clinicopathological features of idiopathic nodular glomerulosclerosis (ING) in Chinese patients, on which there has been no previously published information.

Methods

Native kidney biopsies performed at a kidney histopathological center in Shanghai between January 1, 2009 and December 31, 2011 were retrospectively examined and relevant clinical data were reviewed.

Results

All kidney biopsy specimens (3,480) were examined. After excluding specimens from patients with diabetes, fasting hyperglycemia or hemoglobin A1c elevation and other known entities associated with nodular glomerulosclerosis, 20 ING cases (1 in 174 biopsies) were identified. Patients with ING had a median age of 55.5 years, 16 (80 %) were male, 19 (95 %) had a body mass index (BMI) ≥25 kg/m2 [BMI ≥30 in 8 (40 %)], 18 (90 %) were hypertensive, 17 (85 %) had a history of cigarette smoking (mean pack-years 19.8 ± 2.4), and 10 (50 %) had hyperlipidemia. All 20 patients had >1 g/day proteinuria with a mean of 2.85 ± 0.33 g/day (seven had nephrotic-range proteinuria). Mean serum creatinine at the time of kidney biopsy was 4.23 ± 0.53 mg/dL (338.2 ± 44.7 μmol/L). Histopathologically, all specimens showed varying degrees of nodular glomerulosclerosis, glomerular basement membrane thickening, foot process effacement, interstitial fibrosis and arterial hyalinosis/sclerosis. Immunofluorescence was non-specific. At follow-up of 22.1 ± 1.15 days post-biopsy, six patients had developed end-stage renal failure and five had worsening serum creatinine concentrations not requiring dialysis.

Conclusion

ING is rare and appears to be associated with overweight, hypertension and cigarette smoking in Chinese patients.
Literature
1.
go back to reference Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol. 1936; 12(1):83–98.7. Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol. 1936; 12(1):83–98.7.
2.
go back to reference Souraty P, et al. Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetes. Nat Clin Pract Nephrol. 2008;4(11):639–42.PubMedCrossRef Souraty P, et al. Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetes. Nat Clin Pract Nephrol. 2008;4(11):639–42.PubMedCrossRef
3.
go back to reference Kwok S, et al. An unusual case of nephrotic syndrome and glucosuria. Am J Kidney Dis. 2012;59(5):734–7.PubMedCrossRef Kwok S, et al. An unusual case of nephrotic syndrome and glucosuria. Am J Kidney Dis. 2012;59(5):734–7.PubMedCrossRef
4.
go back to reference Kinoshita C, et al. A case of idiopathic nodular glomerulosclerosis with fibrin caps. Clin Exp Nephrol. 2011;15(6):937–41.PubMedCrossRef Kinoshita C, et al. A case of idiopathic nodular glomerulosclerosis with fibrin caps. Clin Exp Nephrol. 2011;15(6):937–41.PubMedCrossRef
5.
go back to reference Jo Y, et al. A case of diabetic glomerulosclerosis without concurrent diabetes mellitus. Nihon Jinzo Gakkai Shi. 2002;44(7):552–7.PubMed Jo Y, et al. A case of diabetic glomerulosclerosis without concurrent diabetes mellitus. Nihon Jinzo Gakkai Shi. 2002;44(7):552–7.PubMed
6.
go back to reference Grcevska L, Polenakovic M, Petrusevska G. Diabetic glomerulosclerosis without overt diabetes mellitus. Nephron. 2002;90(1):106–8.PubMedCrossRef Grcevska L, Polenakovic M, Petrusevska G. Diabetic glomerulosclerosis without overt diabetes mellitus. Nephron. 2002;90(1):106–8.PubMedCrossRef
7.
go back to reference Strauss FG, Argy WP Jr, Schreiner GE. Diabetic glomerulosclerosis in the absence of glucose intolerance. Ann Intern Med. 1971;75(2):239–42.PubMedCrossRef Strauss FG, Argy WP Jr, Schreiner GE. Diabetic glomerulosclerosis in the absence of glucose intolerance. Ann Intern Med. 1971;75(2):239–42.PubMedCrossRef
8.
go back to reference Nash DA Jr, et al. Diabetic glomerulosclerosis without glucose intolerance. Am J Med. 1975;59(2):191–9.PubMedCrossRef Nash DA Jr, et al. Diabetic glomerulosclerosis without glucose intolerance. Am J Med. 1975;59(2):191–9.PubMedCrossRef
9.
go back to reference Mactier RA, Luger A, Khanna R. Diabetic glomerulosclerosis without concurrent diabetes mellitus. South Med J. 1988;81(12):1573–7.PubMedCrossRef Mactier RA, Luger A, Khanna R. Diabetic glomerulosclerosis without concurrent diabetes mellitus. South Med J. 1988;81(12):1573–7.PubMedCrossRef
10.
go back to reference Alpers CE, Biava CG. Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity. Clin Nephrol. 1989;32(2):68–74.PubMed Alpers CE, Biava CG. Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity. Clin Nephrol. 1989;32(2):68–74.PubMed
11.
go back to reference Macrae J, Nicastri A, Chen CK. Diabetic nephropathy without hyperglycemia. J Diabet Complications. 1990;4(3):126–31.PubMedCrossRef Macrae J, Nicastri A, Chen CK. Diabetic nephropathy without hyperglycemia. J Diabet Complications. 1990;4(3):126–31.PubMedCrossRef
12.
go back to reference Kanwar YS, Garces J, Molitch ME. Occurrence of intercapillary nodular glomerulosclerosis in the absence of glucose intolerance. Am J Kidney Dis. 1990;15(3):281–3.PubMedCrossRef Kanwar YS, Garces J, Molitch ME. Occurrence of intercapillary nodular glomerulosclerosis in the absence of glucose intolerance. Am J Kidney Dis. 1990;15(3):281–3.PubMedCrossRef
13.
go back to reference Markowitz GS, et al. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol. 2002;33(8):826–35.PubMedCrossRef Markowitz GS, et al. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol. 2002;33(8):826–35.PubMedCrossRef
14.
go back to reference Navaneethan SD, Singh S, Choudhry W. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature. J Nephrol. 2005;18(5):613–5.PubMed Navaneethan SD, Singh S, Choudhry W. Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature. J Nephrol. 2005;18(5):613–5.PubMed
15.
go back to reference Kuppachi S, et al. Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker—case report and review of literature. Nephrol Dial Transplant. 2006;21(12):3571–5.PubMedCrossRef Kuppachi S, et al. Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker—case report and review of literature. Nephrol Dial Transplant. 2006;21(12):3571–5.PubMedCrossRef
16.
go back to reference Nasr SH, D’Agati VD. Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol. 2007;18(7):2032–6.PubMedCrossRef Nasr SH, D’Agati VD. Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol. 2007;18(7):2032–6.PubMedCrossRef
17.
go back to reference Liang KV, et al. Nodular glomerulosclerosis: renal lesions in chronic smokers mimic chronic thrombotic microangiopathy and hypertensive lesions. Am J Kidney Dis. 2007;49(4):552–9.PubMedCrossRef Liang KV, et al. Nodular glomerulosclerosis: renal lesions in chronic smokers mimic chronic thrombotic microangiopathy and hypertensive lesions. Am J Kidney Dis. 2007;49(4):552–9.PubMedCrossRef
18.
go back to reference Li W, Verani RR. Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases. Hum Pathol. 2008;39(12):1771–6.PubMedCrossRef Li W, Verani RR. Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases. Hum Pathol. 2008;39(12):1771–6.PubMedCrossRef
19.
go back to reference Kasmani R, et al. The other end of spectrum in hypertension: ‘idiopathic nodular glomerulosclerosis’. Int Urol Nephrol. 2010;42(3):857–9.PubMedCrossRef Kasmani R, et al. The other end of spectrum in hypertension: ‘idiopathic nodular glomerulosclerosis’. Int Urol Nephrol. 2010;42(3):857–9.PubMedCrossRef
20.
go back to reference Kusaba T, et al. Idiopathic nodular glomerulosclerosis: three Japanese cases and review of the literature. Clin Nephrol. 2007;67(1):32–7.PubMedCrossRef Kusaba T, et al. Idiopathic nodular glomerulosclerosis: three Japanese cases and review of the literature. Clin Nephrol. 2007;67(1):32–7.PubMedCrossRef
21.
go back to reference Suzuki S, et al. Nodular glomerulosclerosis of unknown origin associated with the nephrotic syndrome. Nephron. 1994;66(4):462–9.PubMedCrossRef Suzuki S, et al. Nodular glomerulosclerosis of unknown origin associated with the nephrotic syndrome. Nephron. 1994;66(4):462–9.PubMedCrossRef
22.
go back to reference Kikuta T, et al. Association between long-term smoking and hypertension and early-onset nodular glomerulosclerosis. Nihon Jinzo Gakkai Shi. 2010;52(7):959–65.PubMed Kikuta T, et al. Association between long-term smoking and hypertension and early-onset nodular glomerulosclerosis. Nihon Jinzo Gakkai Shi. 2010;52(7):959–65.PubMed
23.
go back to reference Sanai T, et al. Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus. Nephrology (Carlton). 2007;12(1):69–73.CrossRef Sanai T, et al. Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus. Nephrology (Carlton). 2007;12(1):69–73.CrossRef
24.
go back to reference Jensen R, Larsen VS. Nodular mesangial glomerulosclerosis in patients without manifest diabetes mellitus. Int Urol Nephrol. 1990;22(1):95–103.PubMedCrossRef Jensen R, Larsen VS. Nodular mesangial glomerulosclerosis in patients without manifest diabetes mellitus. Int Urol Nephrol. 1990;22(1):95–103.PubMedCrossRef
25.
go back to reference Innes A, et al. Diabetic glomerulosclerosis without diabetes mellitus–two case reports and a review of the literature. Nephrol Dial Transplant. 1992;7(7):642–6.PubMed Innes A, et al. Diabetic glomerulosclerosis without diabetes mellitus–two case reports and a review of the literature. Nephrol Dial Transplant. 1992;7(7):642–6.PubMed
26.
go back to reference da Silva EC, et al. Nodular diabetic glomerulosclerosis without diabetes mellitus. Nephron. 1992;62(3):289–91.PubMedCrossRef da Silva EC, et al. Nodular diabetic glomerulosclerosis without diabetes mellitus. Nephron. 1992;62(3):289–91.PubMedCrossRef
27.
go back to reference Costa AF, et al. Nodular glomerulosclerosis in a non-diabetic hypertensive smoker with dyslipidemia. An Sist Sanit Navar. 2011;34(2):301–8.PubMedCrossRef Costa AF, et al. Nodular glomerulosclerosis in a non-diabetic hypertensive smoker with dyslipidemia. An Sist Sanit Navar. 2011;34(2):301–8.PubMedCrossRef
28.
go back to reference Gonzalo A, et al. Nodular glomerulosclerosis without glucose intolerance: long-term follow-up. Nephron. 1994;66(4):481–2.PubMedCrossRef Gonzalo A, et al. Nodular glomerulosclerosis without glucose intolerance: long-term follow-up. Nephron. 1994;66(4):481–2.PubMedCrossRef
29.
30.
go back to reference Chang CS, Yang AH, Chang CH. Nodular glomerulosclerosis mimicking diabetic nephropathy without overt diabetes mellitus. Clin Nephrol. 2005;64(4):300–4.PubMedCrossRef Chang CS, Yang AH, Chang CH. Nodular glomerulosclerosis mimicking diabetic nephropathy without overt diabetes mellitus. Clin Nephrol. 2005;64(4):300–4.PubMedCrossRef
31.
go back to reference Muller-Hocker J, et al. A case of idiopathic nodular glomerulosclerosis mimicking diabetic glomerulosclerosis (Kimmelstiel–Wilson type). Pathol Res Pract. 2002;198(5):375–9.PubMedCrossRef Muller-Hocker J, et al. A case of idiopathic nodular glomerulosclerosis mimicking diabetic glomerulosclerosis (Kimmelstiel–Wilson type). Pathol Res Pract. 2002;198(5):375–9.PubMedCrossRef
32.
go back to reference Kambham N, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498–509.PubMedCrossRef Kambham N, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498–509.PubMedCrossRef
33.
go back to reference Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36(Suppl 1):S67–S74. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36(Suppl 1):S67–S74.
34.
go back to reference Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.PubMedCrossRef Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.PubMedCrossRef
35.
go back to reference Iseki K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65(5):1870–6.PubMedCrossRef Iseki K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65(5):1870–6.PubMedCrossRef
36.
go back to reference Chagnac A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278(5):F817–22.PubMed Chagnac A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278(5):F817–22.PubMed
37.
go back to reference D’Agati VD, Markowitz GS. Supersized kidneys: lessons from the preclinical obese kidney. Kidney Int. 2008;73(8):909–10.PubMedCrossRef D’Agati VD, Markowitz GS. Supersized kidneys: lessons from the preclinical obese kidney. Kidney Int. 2008;73(8):909–10.PubMedCrossRef
38.
go back to reference Wiggins JE, et al. Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol. 2005;16(10):2953–66.PubMedCrossRef Wiggins JE, et al. Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol. 2005;16(10):2953–66.PubMedCrossRef
39.
go back to reference Wiecek A, et al. The adipose tissue—a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant. 2002;17(2):191–5.PubMedCrossRef Wiecek A, et al. The adipose tissue—a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant. 2002;17(2):191–5.PubMedCrossRef
40.
go back to reference Sharma K, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Investig. 2008;118(5):1645–56.PubMedCentralPubMed Sharma K, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Investig. 2008;118(5):1645–56.PubMedCentralPubMed
41.
go back to reference Wolf G, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [see comments]. Kidney Int. 1999;56(3):860–72.PubMedCrossRef Wolf G, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [see comments]. Kidney Int. 1999;56(3):860–72.PubMedCrossRef
42.
go back to reference Bernstein KE, et al. A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev. 2013;65(1):1–46.PubMedCentralPubMedCrossRef Bernstein KE, et al. A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev. 2013;65(1):1–46.PubMedCentralPubMedCrossRef
43.
44.
go back to reference Buckalew VM Jr, et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis. 1996;28(6):811–21.PubMedCrossRef Buckalew VM Jr, et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis. 1996;28(6):811–21.PubMedCrossRef
45.
go back to reference Cryer PE, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295(11):573–7.PubMedCrossRef Cryer PE, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295(11):573–7.PubMedCrossRef
46.
47.
go back to reference Ritz E, et al. Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol. 1998;9(10):1798–804.PubMed Ritz E, et al. Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol. 1998;9(10):1798–804.PubMed
48.
49.
go back to reference Ng MK, et al. A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol. 2007;27(1):106–12.PubMedCrossRef Ng MK, et al. A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol. 2007;27(1):106–12.PubMedCrossRef
50.
go back to reference Heeschen C, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7(7):833–9.PubMedCrossRef Heeschen C, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7(7):833–9.PubMedCrossRef
51.
go back to reference Salani D, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000;157(5):1703–11.PubMedCentralPubMedCrossRef Salani D, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000;157(5):1703–11.PubMedCentralPubMedCrossRef
52.
go back to reference Rodella LF, et al. Endothelin-1 as a potential marker of melatonin’s therapeutic effects in smoking-induced vasculopathy. Life Sci. 2010;87(17–18):558–64.PubMedCrossRef Rodella LF, et al. Endothelin-1 as a potential marker of melatonin’s therapeutic effects in smoking-induced vasculopathy. Life Sci. 2010;87(17–18):558–64.PubMedCrossRef
53.
go back to reference Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord. 2003;27(11):1294–6.PubMedCrossRef Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord. 2003;27(11):1294–6.PubMedCrossRef
Metadata
Title
Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases
Authors
Jun Wu
Shengqiang Yu
Vickram Tejwani
Michael Mao
Angela K. Muriithi
Chaoyang Ye
Xuezhi Zhao
Hongchen Gu
Changlin Mei
Qi Qian
Publication date
01-12-2014
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2014
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0929-y

Other articles of this Issue 6/2014

Clinical and Experimental Nephrology 6/2014 Go to the issue

Acknowledgment

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.